임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

38건 표시

3상모집 중단 (진행 중)· Dry Eye Disease
A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease
리드: 애브비
상세 →NCT07284381
3상모집 중단 (진행 중)· Ulcerative Colitis
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
리드: 애브비
상세 →NCT06880744
3상모집 중단 (진행 중)· Mid Face Volume Deficit
A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult Participants
리드: 애브비
상세 →NCT07032597
3상모집 중단 (진행 중)· Menstrual Migraine (MM)
Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
리드: 애브비
상세 →NCT06806293
3상모집 중단 (진행 중)· Atopic Dermatitis
Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis
리드: 애브비
상세 →NCT06701331
3상모집 중단 (진행 중)· Metastatic Colorectal Cancer
A Study Assessing Adverse Events and Disease Activity of Intravenously (IV) Infused Telisotuzumab Adizutecan in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer
리드: 애브비
상세 →NCT06614192
3상모집 중단 (진행 중)· Migraine
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
리드: 애브비
상세 →NCT06417775
3상모집 중단 (진행 중)· Diffuse Large B-Cell Lymphoma
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
협력: 애브비
상세 →NCT06508658
3상모집 중단 (진행 중)· Hidradenitis Suppurativa
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
리드: 애브비
상세 →NCT06468228
3상모집 중단 (진행 중)· Migraine
Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine
리드: 애브비
상세 →NCT06241313
3상모집 중단 (진행 중)· Vitiligo
A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo
리드: 애브비
상세 →NCT06118411
3상모집 중단 (진행 중)· Atrophic Acne Scars
ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars
리드: 애브비
상세 →NCT05995340
3상모집 중단 (진행 중)· Crohn's Disease
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
리드: 애브비
상세 →NCT06063967
3상모집 중단 (진행 중)· Ulcerative Colitis
Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.
리드: 애브비
상세 →NCT05782907
3상모집 중단 (진행 중)· Systemic Lupus Erythematosus
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
리드: 애브비
상세 →NCT05843643
3상모집 중단 (진행 중)· Rheumatoid Arthritis
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
리드: 애브비
상세 →NCT05814627
3상모집 중단 (진행 중)· Ovarian Cancer
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
리드: 애브비
상세 →NCT05445778
3상모집 중단 (진행 중)· Diffuse Large B-Cell Lymphoma
A Sub-study Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) in China
협력: 애브비
상세 →NCT07226752
3상모집 중단 (진행 중)· Follicular Lymphoma (FL)
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma
협력: 애브비
상세 →NCT05409066
3상모집 중단 (진행 중)· Psoriasis
Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977
리드: 애브비
상세 →NCT04862286
3상모집 중단 (진행 중)· Chronic Lymphoid Leukemia
Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)
협력: 애브비, 얀센(J&J), 로슈
상세 →NCT04608318
3상모집 중단 (진행 중)· Diffuse Large B-cell Lymphoma
A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
협력: 애브비
상세 →NCT04628494
3상모집 중단 (진행 중)· Crohn's Disease (CD)
Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)
리드: 애브비
상세 →NCT04524611
3상모집 중단 (진행 중)· Myelodysplastic Syndrome (MDS)
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
리드: 애브비 · 협력: 로슈
상세 →NCT04401748
3상모집 중단 (진행 중)· Myelofibrosis (MF)
Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis
리드: 애브비
상세 →NCT04468984
3상모집 중단 (진행 중)· Endometriosis
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain
리드: 애브비
상세 →NCT04333576
3상모집 중단 (진행 중)· Takayasu Arteritis (TAK)
A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)
리드: 애브비
상세 →NCT04161898
3상모집 중단 (진행 중)· Chronic Lymphocytic Leukemia
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
리드: 애브비
상세 →NCT03844048
3상모집 중단 (진행 중)· Psoriatic Arthritis
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy
리드: 애브비
상세 →NCT03675308
3상모집 중단 (진행 중)· Psoriatic Arthritis (PsA)
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)
리드: 애브비
상세 →NCT03671148
3상모집 중단 (진행 중)· Multiple Myeloma
A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.
리드: 애브비 · 협력: 로슈
상세 →NCT03539744
3상모집 중단 (진행 중)· Ulcerative Colitis (UC)
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
리드: 애브비
상세 →NCT03398135
3상모집 중단 (진행 중)· Atopic Dermatitis
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
리드: 애브비
상세 →NCT03568318
3상모집 중단 (진행 중)· Crohn's Disease
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
리드: 애브비
상세 →NCT03105102
3상모집 중단 (진행 중)· Crohn's Disease
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433
리드: 애브비
상세 →NCT03345823
3상모집 중단 (진행 중)· Acute Myeloid Leukemia (AML)
A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy
리드: 애브비 · 협력: 로슈
상세 →NCT02993523
3상모집 중단 (진행 중)· Ulcerative Colitis (UC)
A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)
리드: 애브비
상세 →NCT03006068
3상모집 중단 (진행 중)· Rheumatoid Arthritis
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate
리드: 애브비
상세 →NCT02629159

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.